IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

New York Presbyterian Hospital Weill Cornell Medical Center /ID# 269271, New York

Institut Paoli-Calmettes /ID# 269080, Marseille

Roswell Park Cancer Institute /ID# 269266, Buffalo

Istituto Europeo Di Oncologia /ID# 269646, Milan

Hospital MD Anderson Cancer Center Madrid /ID# 269641, Madrid

Azienda Ospedaliero Universitaria Maggiore Della Carità /ID# 269280, Novara

IUCT Oncopole /ID# 269284, Toulouse

Moffitt Cancer Center /ID# 269269, Tampa

IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 269281, Bologna

Cleveland Clinic - Cleveland /ID# 269272, Cleveland

Hospital Universitario y Politecnico La Fe /ID# 269278, Valencia

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST - IRCCS /ID# 269279, Meldola

Universitaetsklinikum Muenster /ID# 269688, Münster

Mayo Clinic Hospital Rochester /ID# 269643, Rochester

Hospices Civils de Lyon - Centre Hospitalier Lyon-Sud /ID# 269286, Pierre-Bénite

Hôpital Saint-Louis /ID# 269282, Paris

Centre Hospitalier de Versailles André Mignot /ID# 269287, Le Chesnay

Universitaetsklinikum Ulm /ID# 269686, Ulm

City of Hope National Medical Center /ID# 269273, Duarte

University Of California Irvine Medical Center /ID# 269275, Orange

Fred Hutchinson Cancer Research Center /ID# 269270, Seattle

Northwestern University- Robert H. Lurie Comprehensive Cancer Center /ID# 269642, Chicago

Dana-Farber Cancer Institute /ID# 269267, Boston

University of Michigan /ID# 269079, Ann Arbor

Duke University Health System /ID# 269268, Durham

MD Anderson Houston /ID# 269265, Houston

Centre Antoine-Lacassagne /ID# 269285, Nice

Universitaetsklinikum Leipzig /ID# 269682, Leipzig

Oxford University Hospital NHS Trust /ID# 269647, Oxford